ClassID:

93319

C07C305/24 - CPC Classification

Classification description:

Esters of sulfuric acids having oxygen atoms of sulfate groups bound to carbon atoms of six-membered aromatic rings of non-condensed six-membered aromatic rings

Recent Application in this class:
#1
20250162986
2025-05-22

Compounds and compositions for neurodegenerative diseases

#2
20250132389
2025-04-24

ELECTROLYTE ADDITIVE, ELECTROLYTE, AND LITHIUM ION SECONDARY BATTERY INCLUDING SAME

#3
20250019345
2025-01-16

NEW CANNABINOID-GABAPENTINOID CONJUGATES AND USES THEREOF

#4
20240317789
2024-09-26

PRODRUGS OF TAPINAROF

#5
20240287002
2024-08-29

METABOLITES OF N-(4-{[6,7-BIS(METHYLOXY)QUINOLIN-4-YL]OXY}PHENYL)-N'-(4-FLUOROPHENYL)CYCLOPROPANE-1,1-DICARBOXAMIDE

#6
20230339850
2023-10-26

CANNABINOID SULFATE ESTERS, THEIR SALTS AND USES THEREOF

#7
20210002228
2021-01-07

Metabolites of N-(4-{[6,7-Bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide

#8
20190218182
2019-07-18

Metabolites of N-(4-{[6,7-Bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide

#9
20180118669
2018-05-03

Process for the preparation of a sulfated derivative of 3,5-diiodo-o-[3-iodophenyl]-l-tyrosine

#10
20160090355
2016-03-31

Sulfonium salt, resist composition and resist pattern forming process

#11
20160031818
2016-02-04

Metabolites of N-{4-([6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide

#12
20150353471
2015-12-10

Xanthine oxidase inhibitors and methods of use

#13
20140155286
2014-06-05

Modified tyrosine amino acids, peptides containing them, and their use for detecting hydrolase enzyme activity

#14
20140080904
2014-03-20

Cinnamic acid-based oligomers and uses thereof

#15
20140005149
2014-01-02

Substituted diphenyl derivatives

#16
20120277169
2012-11-01

NYASOL AND ANALOGS THEREOF FOR THE TREATMENT OF ESTROGEN RECEPTOR BETA-MEDIATED DISEASES

#17
20120213758
2012-08-23

BIARYL PDE4 INHIBITORS FOR TREATING PULMONARY AND CARDIOVASCULAR DISORDERS

#18
20120183522
2012-07-19

Biaryl PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disorders

#19
20120027691
2012-02-02

Cinnamic acid-based oligomers and uses thereof

#20
20110263699
2011-10-27

1-Phenyl-2-DimethylaminomethylCyclohexane Compounds and Therapies for Depressive Symptoms, Pain and Incontinence

#21
20100129471
2010-05-27

Iso CA-4 and analogues thereof as potent cytotoxic agents inhibiting tubuline polymerization

#22
20100010232
2010-01-14

Aryl derivatives of curcumin, demethoxycurcumin, bisdemethoxycurcumin or curcuminisoxazolide and their use as animal feed additives

#23
20090324569
2009-12-31

BIARYL PDE4 INHIBITORS FOR TREATING INFLAMMATORY, CARDIOVASCULAR AND CNS DISORDERS

#24
20090318556
2009-12-24

BIOMARKERS FOR DETECTING RADIATION EXPOSURE: METHODS AND USES THEREOF

#25
20090312274
2009-12-17

Nyasol and Analogs Thereof for the Treatment of Estrogen Receptor Beta-Mediated Diseases

#26
20090136473
2009-05-28

BIARYL PDE4 INHIBITORS FOR TREATING PULMONARY AND CARDIOVASCULAR DISORDERS

#27
20090124690
2009-05-14

Generation of Combinatorial Synthetic Libraries and Screening for Novel Proadhesins and Nonadhesins

#28
20080234369
2008-09-25

3,4,5,4′-tetramethoxyl-α,β-diphenylethane-3′-O-sodium sulphate and its use

#29
20080167347
2008-07-10

Ctgf Expression Inhibitor

#30
20050182131
2005-08-18

1-Phenyl-2-dimethylaminomethyl cyclohexane compounds and therapies for depressive symptoms, pain and incontinence

#31
20050181455
2005-08-18

Generation of combinatorial synthetic libraries and screening for novel proadhesins and nonadhesins